Skip to main content

Table 4 parameters of metabolism, hemostasis, endogenous fibrinolysis and blood rheology for patients with and without diabetes mellitus

From: Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients

  diabetes mellitus non-diabetic patients p-value
  n = 44 n = 194  
total cholesterol (mg/dl) 254 ± 69 239 ± 43 n.s.
hdl - cholesterol(mg/dl) 42 ± 13 45 ± 12 <0,05
ldl - cholesterol(mg/dl) 188 ± 55 173 ± 43 <0,05
triglycerides (mg/dl) 257 ± 204 183 ± 103 <0,05
lipoproteine (a) (mg/dl) 22 ± 33 36 ± 42 <0,05
glucose (mg/dl) 157 ± 67 88 ± 12 <0,0001
tissue -plasminogenactivator (μg/l) 8,9 ± 3,7 8,4 ± 3,0 n.s.
plasminogenaktivator-inhibitore (U/ml) 6,1 ± 5,2 4,8 ± 2,7 <0,05
fibrinogen (mg/dl) 351 ± 76 312 ± 64 <0,01
plasma viscosity (mPa × s-1) 1,38 ± 0,23 1,31 ± 0,16 <0,01
red blood cell aggregation M (E) 8,7 ± 2,1 7,3 ± 2,0 <0,05
red blood cell aggregation M1 (E) 13,2 ± 2,5 12,1 ± 3,1 <0,05